This week on the Kingscrowd Podcast, Brian Belley and Léa Bouhelier-Gautreau discuss Kingscrowd's recommendations to the SEC regarding private market investing and startup fundraising. They explain why mandatory valuation disclosure, better investor updates, and improved exit transparency could significantly improve the online private investing experience. The conversation highlights several practical reforms that could help investors make better-informed decisions and increase accountability across Regulation Crowdfunding offerings.

The episode then shifts to a deep dive on Harmony Baby Nutrition, a company developing infant and toddler formulas using human milk proteins produced through precision fermentation. Léa explains the company's phased commercialization strategy, why the opportunity resembles a biotech investment more than a traditional consumer products company, and how Harmony hopes to bridge the gap between conventional formula and human breast milk. The discussion covers regulatory hurdles, funding strategy, market demand, and why Kingscrowd Capital selected Harmony Baby Nutrition as a Top Deal.

Highlights include...

Investors should always know the valuation of a company before investing.
Many crowdfunding issuers still fail to provide meaningful ongoing investor updates.
Better transparency around exits would significantly improve the investor experience.
Harmony Baby Nutrition is pursuing a phased commercialization strategy to reduce execution risk.
The company is targeting one of the most emotionally driven consumer markets: infant nutrition.
Human milk proteins already exist; Harmony's challenge is commercializing them in formula products.
Harmony should be evaluated more like a biotech company than a traditional CPG startup.
Strategic milestone products may help Harmony generate revenue before its flagship vision is fully realized.
Strong venture backing provides additional validation for the opportunity.
If successful, Harmony could help redefine the infant formula category.